Copper Complexes: Dr. Fernando Vieira on ALS TDI's Promising Potential ALS Treatment - a podcast by ALS TDI

ALS TDI’s primary mission is to discover treatments for everyone with ALS. Every day, our scientists are testing drugs to find the next compound with the potential to make it to clinical trials and beyond. Currently, one of our most promising leads is a group of molecules called copper complexes.

These copper complexes, also referred to as redox metabolism modulators, have demonstrated signs of efficacy in ALS TDI’s cellular and animal models of ALS. Currently, our scientists are hard at work looking for a lead molecule to advance toward clinical trials.

Today, on Endpoints, we’re joined by Dr. Fernando Vieira, ALS TDI’s CEO and CSO, to tell us more about what copper complexes are, how ALS TDI discovered their potential for treating ALS, and where they are in the drug development process.

Support the show: https://www.als.net/donate/

See omnystudio.com/listener for privacy information.

Further episodes of Endpoints

Further podcasts by ALS TDI

Website of ALS TDI